Curaleaf Holdings Files 6-K, Signals 40-F Annual Report

Ticker: CURLF · Form: 6-K · Filed: 2024-11-12T00:00:00.000Z

Sentiment: neutral

Topics: reporting, regulatory-filing

TL;DR

Curaleaf filed a 6-K, confirming they'll file a 40-F annual report. Standard procedure.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on November 12, 2024, indicating it will file its annual report under Form 40-F. The filing also includes Exhibit 99.1, which is a press release, though its content is not detailed in this excerpt. The company's principal executive office is located in Vancouver, British Columbia, Canada.

Why It Matters

This filing indicates Curaleaf is adhering to its reporting obligations, which is crucial for investor confidence and regulatory compliance in the cannabis industry.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming reporting status and including a press release, with no new financial or operational disclosures presented in this excerpt.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing by Curaleaf Holdings, Inc.?

The Form 6-K filing serves to report that Curaleaf Holdings, Inc. will file its annual report under cover of Form 40-F and includes Exhibit 99.1, a press release.

Which form will Curaleaf Holdings, Inc. use for its annual report filing?

Curaleaf Holdings, Inc. will file its annual report under cover of Form 40-F.

Who signed this Form 6-K on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the Form 6-K on behalf of Curaleaf Holdings, Inc.

What is the filing date of this report?

The filing date of this report is November 12, 2024.

Where are Curaleaf Holdings, Inc.'s principal executive offices located?

Curaleaf Holdings, Inc.'s principal executive offices are located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

From the Filing

0001756770-24-000068.txt : 20241112 0001756770-24-000068.hdr.sgml : 20241112 20241112104612 ACCESSION NUMBER: 0001756770-24-000068 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20241112 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241445111 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover110624.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: November 12, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated November 6 , 2024 EX-99.1 2 pressrelease110624.htm EX-99.1 Document Curaleaf Secures New $40 Million Revolving Credit Facility The new revolving line of credit will support ongoing working capital needs STAMFORD, CT, November 6, 2024 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it successfully completed a new $40 million revolving credit facility with a major commercial regional bank. The credit line will be available to be drawn down as needed for general corporate purposes and working capital needs. Boris Jordan, Curaleaf Chairman and Chief Executive Officer, commented, "In my first few months in my new role as CEO, I’ve been focused on cost-savings measures across every facet of the business, with the intent of driving profitable growth. With our new revolving credit facility, we will have an opportunity to better support various business needs across the globe. This is a milestone event for Curaleaf as this credit line provides flexibility traditionally not available to the cannabis sector, and allows us to continue growing Curaleaf as the leader of the global cannabis industry during what continues to be a difficult capital raising environment.” The new two-year secured revolving credit facility has a maturity date of December 15, 2026. Borrowings under the facility bear interest on any outstanding principal of 7.99%. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find, The Hemp Company and Zero Proof provide industry

View on Read The Filing